Search results
Novavax is powered by global collaborations. We are a biotechnology company committed to addressing serious infectious diseases globally through the discovery and development of innovative vaccines.
- Press Releases
Novavax creates transformational vaccines that help address...
- Careers
Novavax will not pay a fee to any recruiting vendor, agency,...
- News & Media
Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that...
- Medical Professionals
The Novavax IIS program supports clinical and non-clinical...
- Matrix-M Adjuvant
The first adjuvant was added to a vaccine over 100 years...
- Science & Technology
Novavax creates transformational vaccines that address some...
- What Is Novavax?
Our mission. We never rest in our quest to protect the...
- Press Releases
Oct 16, 2023 · Novavax’s protein-based vaccine is the latest FDA-authorized COVID booster available this fall. Here’s what you should know. By Sara Reardon. A health care worker prepares a dose of Novavax...
The FDA has determined that the Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) has met the statutory criteria for issuance of an EUA, and that the known and potential benefits of the...
The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [1] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI). [29] Medical uses. The Novavax COVID‑19 vaccine is indicated for active immunization to prevent COVID‑19 caused by SARS-CoV-2. [4]
- AU: B1
- Intramuscular
- Covovax, Nuvaxovid
- SARS-CoV-2
Jun 6, 2023 · Novavax COVID-19 Vaccine, Adjuvanted is available under emergency use authorization (EUA) to prevent COVID-19 in individuals 12 years of age and older. The vaccine is authorized for emergency use...
Sep 12, 2023 · October 3, 2023. This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based non-mRNA COVID vaccine option in the U.S. Novavax expects doses will be available in thousands of locations across the U.S. in the coming days, including CVS Pharmacy and Rite Aid.
Dec 21, 2021 · The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim policy recommendations for the use of the Novavax (NVX-CoV2373) vaccine. This article provides a summary of those interim recommendations. For the purposes of this article, the vaccine will be referred to as Novavax (NVX-CoV2373).
Ad
related to: NovavaxConsistent, stable temperatures within 2-8 C (36-46 F) for up to 3 days. Simplifies vaccine transport & offsite vaccine management. Easy preparation and packout.